Ingersoll Rand Inc. (NYSE:IR) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. And welcome to the Ingersoll Rand First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
Stay updated with breaking news from Medical Components. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Thank you for standing by. And welcome to the Ingersoll Rand First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
Vascular Access Catheters marketThe global vascular access catheters market sales is anticipated to develop at a compound annual growth rate (CAGR) of 5.7% between 2022 and 2032, providing lucrative growth potential estimated at US$ 5.3 billion. By the end of 2022, the non-antimicrobial category is predicted to acco...
/PRNewswire/ -- By participating in the MD&M West 2024 fair, the largest medical device fair in the United States, the Trade and Investment Promotion Agency of...
There’s nothing scary for Ametek Inc. shareholders in the $1.9 billion acquisition of Paragon Medical Inc. announced on Oct. 31, 2023. The deal moves the industrial technology company solidly into the med-tech space as it picks up Paragon’s portfolio of products in orthopedics, minimally invasive surgery, robotic surgery and drug delivery, and adds an estimated $500 million per year in revenue and “very strong EPS accretion,” Ametek CEO David Zapico said in an investor call on Oct. 31.
Pharmaceutical Contract Manufacturing Market Share is Estimated to Witness Healthy Valuation of USD 179.4 Billion at a 6.00% CAGR by 2030